Photo Source: Babushahi Network
Mohali: 10,000 tablets seized from factories and shops by health teams
Joint inspection by central and district health teams in Mohali, Kharar and Kurali
Substandard/Misbranded health supplement manufacturers are on FDA's radar: B.S. Acharya
Mohali, September 17, 2021:
To enforce Nutracutical and health supplement regulation by Food Safety and Standards authority of India (FSSAI), a joint surprise inspection was conducted on wholesalers, retailers and manufacturing units at Mohali, Kharar and Kurali. The inspection team consisted of B.S. Acharya-Joint director and Central licensing authority of FSSAI and Mohali District Health officer (DHO) Dr Subhash Kumar along with food safety officer Ravinandan Goyal.
During surprise checks, 10,000 tablets of CanDZ were seized by the authorities as these were found to be non-compliant with regulations of FSSAI. Mr. Acharya informed that the tablet Demci-500 was also ordered to be recalled by the Manufacturer after it was found to be non-compliant with the norms. A search for Demci-500 was also carried out in many parts of the region. One manufacturing unit in Kurali was also visited and a notice was issued to it for adhering to all health supplement regulation of FSSAI act. He asserted that the state unit of the Food and Drug Administration (FDA) is very much vigilant about Substandard / misbranded health supplements and the department will not be lenient in enforcement of the norms. He added that manufacturer and marketer both were told to recall the entire batch of the above mentioned Tablets.
B.S Acharya further said that all Nutracutical manufacturing companies need to obtain a central license. Even if any manufacturing unit has a state license, they need to convert it to a central license via applying for modification in the FSSAI portal. License number will not be changed in this procedure. He said that all the Food Business Operators (FBO) manufacturing health supplements and Nutraceuticals products were advised to rectify their labels as per labeling and claim regulations of FSSAI to prevent further action from FSSAI/FDA.